tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

BTAI Stock Latest News

BioXcel Therapeutics Reports Q2 2025 Financial Results
Company AnnouncementsBioXcel Therapeutics Reports Q2 2025 Financial Results
19h ago
BTAI
BioXcel Therapeutics trading resumes
PremiumThe Fly
BioXcel Therapeutics trading resumes
1d ago
BTAI
BioXcel Therapeutics trading halted, volatility trading pause
PremiumThe Fly
BioXcel Therapeutics trading halted, volatility trading pause
1d ago
BTAI
BioXcel Therapeutics reports Q2 EPS ($2.45), consensus ($1.56)
PremiumThe Fly
BioXcel Therapeutics reports Q2 EPS ($2.45), consensus ($1.56)
1d ago
BTAI
BioXcel Therapeutics Raises $30.4M, Meets Financing Covenant
PremiumCompany Announcements
BioXcel Therapeutics Raises $30.4M, Meets Financing Covenant
2d ago
8K
BTAI
BioXcel’s BXCL501 Study: A Potential Game-Changer for Psychomotor Agitation Treatment
PremiumCompany AnnouncementsBioXcel’s BXCL501 Study: A Potential Game-Changer for Psychomotor Agitation Treatment
2d ago
BTAI
BioXcel Highlights BXCL501’s Market Potential for Agitation
Premium
Company Announcements
BioXcel Highlights BXCL501’s Market Potential for Agitation
2d ago
8K
BTAI
BTAI Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
BTAI Earnings this Week: How Will it Perform?
4d ago
BTAI
3 Penny Stocks to Watch Now, 8/7/25
PremiumMarket News
3 Penny Stocks to Watch Now, 8/7/25
7d ago
ASX
AIMD
BioXcel Study Highlights Dexmedetomidine’s Potential Benefits
PremiumCompany Announcements
BioXcel Study Highlights Dexmedetomidine’s Potential Benefits
7d ago
8K
BTAI
BioXcel Therapeutics announces publication on active ingredient in BXCL-501
PremiumThe Fly
BioXcel Therapeutics announces publication on active ingredient in BXCL-501
7d ago
BTAI
3 Penny Stocks to Watch Now, 8/5/25
PremiumMarket News
3 Penny Stocks to Watch Now, 8/5/25
8d ago
BTAI
IMAB
Bioxcel Therapeutics: Buy Rating Driven by SERENITY Trial Milestone and Strategic Expansion
PremiumRatingsBioxcel Therapeutics: Buy Rating Driven by SERENITY Trial Milestone and Strategic Expansion
10d ago
BTAI
BioXcel Completes Phase 3 Trial for BXCL501
Premium
Company Announcements
BioXcel Completes Phase 3 Trial for BXCL501
13d ago
8K
BTAI
BioXcel announces last patient visit in SERENITY at-home Phase 3 trial
Premium
The Fly
BioXcel announces last patient visit in SERENITY at-home Phase 3 trial
13d ago
BTAI
BioXcel Therapeutics: Buy Rating Affirmed Amidst Pre-sNDA Submission and Upcoming SERENITY At-Home Trial Results
PremiumRatings
BioXcel Therapeutics: Buy Rating Affirmed Amidst Pre-sNDA Submission and Upcoming SERENITY At-Home Trial Results
23d ago
BTAI
BioXcel Submits IGALMI® Application for FDA Review
PremiumCompany Announcements
BioXcel Submits IGALMI® Application for FDA Review
23d ago
8K
BTAI
BioXcel Therapeutics submits pre-supplemental NDA meeting package for IGALMI
PremiumThe Fly
BioXcel Therapeutics submits pre-supplemental NDA meeting package for IGALMI
24d ago
BTAI
Lucid reiterates Buy on BioXcel after patent application approval
PremiumThe Fly
Lucid reiterates Buy on BioXcel after patent application approval
29d ago
BTAI
BioXcel Therapeutics announces patent allowance for dexmedetomidine
PremiumThe FlyBioXcel Therapeutics announces patent allowance for dexmedetomidine
29d ago
BTAI
BioXcel Granted Patent for Dexmedetomidine Use
Premium
Company Announcements
BioXcel Granted Patent for Dexmedetomidine Use
29d ago
8K
BTAI
Positive Buy Rating for Bioxcel Therapeutics Driven by Promising Phase 3 Trial Developments and Valuation Alignment
Premium
Ratings
Positive Buy Rating for Bioxcel Therapeutics Driven by Promising Phase 3 Trial Developments and Valuation Alignment
1M ago
BTAI

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >